The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Toxins Année : 2017

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

Résumé

The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three BoNT serotypes were targeted to achieve a synergistic effect (oligoclonal antibodies). For antibody isolation, macaques were immunized with the recombinant and non-toxic BoNT/A, B or E, HC or LC, followed by the generation of immune phage-display libraries. Antibodies were selected from these libraries against the holotoxin and further analyzed in in vitro and ex vivo assays. For each library, the best ex vivo neutralizing antibody fragments were germline-humanized and expressed as immunoglobulin G (IgGs). The IgGs were tested in vivo, in a standardized model of protection, and challenged with toxins obtained from collections of Clostridium strains. Protective antibody combinations against BoNT/A and BoNT/B were evidenced and for BoNT/E, the anti-LC antibody alone was found highly protective. The combination of these five antibodies as an oligoclonal antibody cocktail can be clinically and regulatorily developed while their high "humanness" predicts a high tolerance in humans.
Fichier principal
Vignette du fichier
toxins-09-00309-v2.pdf (3.65 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

pasteur-01826737 , version 1 (29-06-2018)

Licence

Paternité

Identifiants

Citer

Christine Rasetti-Escargueil, Avril Arnaud, Miethe Sebastian, Mazuet Christelle, Derman Yagmur, et al.. The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies. Toxins, 2017, 9 (10), pp.309. ⟨10.3390/toxins9100309⟩. ⟨pasteur-01826737⟩

Collections

PASTEUR
274 Consultations
186 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More